Metabolic syndrome and related factors treated with antipsychotics monotherapy and polypharmacy in patients with schizophrenia


Oncu F., Acuner T. T., Atlar F., Turkcan S., Yesilbursa D., Uygur N.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.19, 2009 (SCI-Expanded, TRDizin)

Özet

Objective: The aim of our study was-to determine the prevalence of MetS and to investigate related factors-in the group of inpatients with schizophrenia treated with antipsychotics monotherapy (AM) and polypharmacy (AP).